Showing results (31-40 of 163) with videos related to
Sort By:
Pageof 17
Archiv Der Pharmazie|August 27, 2019
Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR-2 inhibitorsAbdel-Ghany A El-Helby, Helmy Sakr, Ibrahim H Eissa, et al.Archiv Der Pharmazie|April 19, 2022
New quinoxalin-2(1H)-one-derived VEGFR-2 inhibitors: Design, synthesis, in vitro anticancer evaluations, in silico ADMET, and docking studiesKhaled El-Adl, Helmy M Sakr, Reda G Yousef, et al.Plos One|December 3, 2024
Integrated study of Quercetin as a potent SARS-CoV-2 RdRp inhibitor: Binding interactions, MD simulations, and In vitro assaysAhmed M Metwaly, Esmail M El-Fakharany, Aisha A Alsfouk, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|February 16, 2021
Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluationMohamed Hagras, Moshira A El Deeb, Heba S A Elzahabi, et al.Archiv Der Pharmazie|November 23, 2020
Design and discovery of new 1,2,4-triazolo[4,3-c]quinazolines as potential DNA intercalators and topoisomerase II inhibitorsMohamed S Alesawy, Ahmed A Al-Karmalawy, Eslam B Elkaeed, et al.Neurochemistry International|May 11, 2020
Tetradecyl 2,3-dihydroxybenzoate alleviates oligodendrocyte damage following chronic cerebral hypoperfusion through IGF-1 receptorMahmoud I Youssef, Yiting Zhou, Ibrahim H Eissa, et al.Bioorganic Chemistry|July 10, 2018
Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducersAhmed A Gaber, Ashraf H Bayoumi, Ahmed M El-Morsy, et al.RSC Advances|July 26, 2023
Design, synthesis, in silico studies, and biological evaluation of novel pyrimidine-5-carbonitrile derivatives as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducersAbdulrahman M Saleh, Hazem A Mahdy, Mohamed Ayman El-Zahabi, et al.RSC Advances|December 12, 2022
Design, synthesis, and biological evaluation of novel bioactive thalidomide analogs as anticancer immunomodulatory agentsAnas Ramadan Kotb, Dina A Bakhotmah, Abdallah E Abdallah, et al.International Journal of Molecular Sciences|August 12, 2022
A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main ProteaseEslam B Elkaeed, Ibrahim H Eissa, Hazem Elkady, et al.Pageof 17